Methylation in p14ARF is frequently observed in colorectal cancer with low-level microsatellite instability

Journal of International Medical Research

Volumn 37, Issue 4, 2009, Pages 1038-1045

  Kominami, K ^a   Nagasaka, T ^a   Cullings, H M ^b   Hoshizima, N ^a   Sasamoto, H ^a   Young, J ^c   Leggett, B A ^c   Tanaka, N ^a   Matsubara, Nagahide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Colorectal cancer; Methylation; Microsatellite instability; p14

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; BRAF PROTEIN, HUMAN; DNA; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ARTICLE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PHENOTYPE; PROMOTER REGION; COLORECTAL TUMOR; GENE SILENCING; GENETICS; INTESTINE MUCOSA; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE SILENCING; HUMANS; INTESTINAL MUCOSA; MICROSATELLITE INSTABILITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 70350500666     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700408     Document Type: Article

References (34)

1. Peltomaki P, Lothe RA, Aaltonen LA, et al: Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 1993; 53: 5853-5855. (Pubitemid 24006147)
2. Young J, Simms LA, Biden KG, et al: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001; 159: 2107-2116. (Pubitemid 33104265)
3. Cunningham JM, Christensen ER, Tester DJ, et al: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-3460.
4. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
5. Jass JR, Biden KG, Cummings MC, et al: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999; 52: 455-460.
6. Watson P, Lin KM, Rodriguez-Bigas MA, et al: Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998; 83: 259-266. (Pubitemid 28317805)
7. Tomlinson I, Halford S, Aaltonen L, et al: Does MSI-low exist? J Pathol 2002; 197: 6-13. (Pubitemid 34450158)
8. Thibodeau SN, French AJ, Cunningham JM, et al: Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998; 58: 1713-1718.
9. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268. (Pubitemid 38256271)
10. Halford S, Sasieni P, Rowan A, et al: Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res 2002; 62: 53-57. (Pubitemid 34073985)
11. Laiho P, Launonen V, Lahermo P, et al: Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 2002; 62: 1166-1170. (Pubitemid 34160304)
12. Mori Y, Selaru FM, Sato F, et al: The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res 2003; 63: 4577-4582. (Pubitemid 36951032)
13. Kambara T, Matsubara N, Nakagawa H, et al: High frequency of low-level microsatellite instability in early colorectal cancer. Cancer Res 2001; 61: 7743-7746. (Pubitemid 33049359)
14. Nagasaka T, Sasamoto H, Notohara K, et al: Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 2004; 22: 4584-4594. (Pubitemid 41185126)
15. Dukes CE: The classification of cancer of the rectum. J Path Bact 1932; 35: 323-332.
16. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976; 3: 2303-2308.
17. Kahn SM, Jiang W, Culbertson TA, et al: Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene 1991; 6: 1079-1083.
18. Xiong Z, Laird PW: COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997; 25: 2532-2534. (Pubitemid 27303718)
19. Rashid A, Shen L, Morris JS, et al: CpG island methylation in colorectal adenomas. Am J Pathol 2001; 159: 1129-1135. (Pubitemid 32847204)
20. Shen L, Kondo Y, Hamilton SR, et al: P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 2003; 124: 626-633. (Pubitemid 36268481)
21. Toyota M, Ahuja N, Ohe-Toyota M, et al: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686. (Pubitemid 29354851)
22. Jass JR, Baker K, Zlobec I, et al: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 2006; 49: 121-131.
23. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
24. Jass JR: Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2004; 2: 1-8. (Pubitemid 38165392)
25. Torlakovic E, Skovlund E, Snover DC, et al: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81. (Pubitemid 36014900)
26. Kambara T, Simms LA, Whitehall VL, et al: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53: 1137-1144. (Pubitemid 38961968)
27. Yang S, Farraye FA, Mack C, et al: BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 2004; 28: 1452-1459. (Pubitemid 39425511)
28. Rosenberg DW, Yang S, Pleau DC, et al: Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 2007; 67: 3551-3554. (Pubitemid 46762136)
29. O'Brien MJ, Yang S, Clebanoff JL, et al: Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 2004; 28: 423-434. (Pubitemid 38436515)
30. Gazin C, Wajapeyee N, Gobeil S, et al: An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007; 449: 1073-1077. (Pubitemid 350014604)
31. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60: 2368-2371.
32. 6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001; 61: 4689-4692.
33. Zhang Y, Xiong Y, Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998; 92: 725-734. (Pubitemid 28155312)
34. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92: 713-723.